BRF (BRFS3) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
14 Jul, 2026Executive summary
Achieved highest quarterly sales volume since the consolidation of BRF in 2022, with record-high volumes in key segments and continued growth in processed products.
Net revenue rose 5.6% year-over-year to R$16,397 million, driven by higher sales volumes in both domestic and international markets and a slight increase in average prices.
Gross profit decreased 4.3% year-over-year to R$4,028 million, with gross margin declining to 24.6% from 27.1% in 3Q24.
Adjusted EBITDA fell 14.9% year-over-year to R$2,526 million, with margin down to 15.4% from 19.1% in 3Q24.
Net income dropped 30.5% year-over-year to R$790 million, with net margin at 4.8%.
Financial highlights
Net revenue: R$16,397 million in Q3 2025 (Q3 2024: R$15,523 million).
Gross profit: R$4,028 million (Q3 2024: R$4,210 million).
Adjusted EBITDA: R$2,526 million (Q3 2024: R$2,968 million).
Net income: R$790 million (Q3 2024: R$1,137 million).
Operating cash flow: R$2,349 million in Q3 2025.
Outlook and guidance
Market diversification and new export authorizations are expected to support international sales despite ongoing export restrictions.
Continued focus on operational efficiency and cost management to offset inflationary pressures and input cost increases.
Management highlights resilience in sales volumes despite avian flu export restrictions.
Ongoing focus on operational efficiency and cost control, with R$355 million in efficiency gains in Q3 and R$868 million year-to-date.
Expansion in international markets, including new joint ventures and market authorizations.
Latest events from BRF
- Record 2Q24: net income R$1.094B, EBITDA R$2.621B, leverage at nine-year low.BRFS3
Q2 202414 Jul 2026 - Record Q3: revenue up 12.4%, EBITDA up 146%, net income R$1.14B, leverage at 0.71x.BRFS3
Q3 202414 Jul 2026 - Record revenue, profit turnaround, and strong cash flow with major deleveraging in 2024.BRFS3
Q4 202414 Jul 2026 - Net income doubled, leverage hit a record low, and a merger with Marfrig was announced.BRFS3
Q1 202514 Jul 2026 - Marfrig merger and record EBITDA drive growth despite export and cost challenges.BRFS3
Q2 202514 Jul 2026 - Net revenue rose 6% to R$65.0bn, with adjusted EBITDA of R$10.4bn and net income of R$3.3bn.BRFS3
Q4 202514 Jul 2026